NuVision

NuVision

NuVision

NuVision™ Biotherapies is a new biotech from the University of Nottingham. We develop ground breaking high quality & affordable biotherapies to tackle blindness
Type
B2c
Founded
2015
Raised
$1.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
£500,000
Seed fund - 2018
Mercia Fund Management Mercia Fund Managers University of Nottingham
£379,000
Seed fund - 2015
Mercia Fund Management
Team Size
2
Employees
FinSMEs

NuVision Biotherapies Raises £1.4m in Funding

£500,000 Seed fund
FinSMEs

NuVision Biotherapies Raises £500K in Funding

Health Science
GSMArena.com

Microsoft offering discount of up to $500 on select PCs, free NuVision tablet included as well

Costs Portable
£379,000 Seed fund
Tech City News

Mercia invests in startup for emergency eye care

Health